Table 1 Characteristics of participants in each survey
Qualitative study n (%) (n = 23) | Delphi first round n (%) (n = 35) | |
|---|---|---|
Years of experience in cancer research | ||
5–9 | 7 (30) | 5 (14) |
10–14 | 2 (9) | 4 (12) |
15–19 | 5 (22) | 4 (12) |
20–24 | 2 (9) | 11 (31) |
25–29 | 5 (21) | 6 (17) |
≥30 | 2 (9) | 5 (14) |
Sex | ||
Male | 16 (70) | 24 (69) |
Female | 7 (30) | 11 (31) |
Institution of affiliation type | ||
Comprehensive cancer centre | 11 (48) | 17 (49) |
University hospital | 6 (26) | 11 (31) |
Public research institute (not affiliated to a hospital or cancer centre) | 2 (9) | 4 (11) |
National agency | 2 (9) | 0 |
International or European agency | 2 (9) | 0 |
Industry (pharmaceutical or consulting) | 0 | 3 (9) |
Country | ||
French institution | 18 (79) | 3 (9) |
Italian institution | 1 (4) | 8 (23) |
Dutch institution | 0 | 6 (17) |
British institution | 0 | 4 (11) |
Belgian institution | 0 | 3 (9) |
Other European country institution | 3 (13) | 11 (31) |
International institution | 1 (4) | 0 |
Training | ||
Masters degree (MSc) | 0 | 1 (3) |
Medical degree (MD) | 2 (9) | 7 (20) |
Medical degree and MSc | 1 (4) | 0 |
Medical degree and PhD | 7 (30) | 14 (40) |
Pharmacy degree (PharmaD) | 1 (4) | 0 |
Pharmacy degree and PhD | 5 (22) | 1 (3) |
PhD | 7 (30) | 12 (34) |
PhD or MSc specialisation | 20 | 28 |
Biology | 10 (50) | 13 (46) |
Chemistry or biochemistry | 2 (10) | 2 (7) |
Pharmacology | 2 (10) | 0 |
Physics | 2 (10) | 2 (7) |
Computer sciences | 1 (5) | 0 |
Management of healthcare organisations | 0 | 2 (7) |
Immunology | 1 (5) | 2 (7) |
Genetics | 1 (5) | 3 (10) |
Epidemiology/statistics | 0 | 2 (7) |
Biotechnology | 1 (5) | 1 (4) |
Pathology | 0 | 1 (4) |